Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
0.0853
-0.0047 (-5.22%)
At close: Dec 20, 2024, 4:00 PM
0.0868
+0.0015 (1.76%)
After-hours: Dec 20, 2024, 7:58 PM EST
Eyenovia Employees
Eyenovia had 57 employees as of December 31, 2023. The number of employees increased by 16 or 39.02% compared to the previous year.
Employees
57
Change (1Y)
16
Growth (1Y)
39.02%
Revenue / Employee
$558
Profits / Employee
-$663,698
Market Cap
9.50M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Jo-Jo Drugstores | 1,003 |
Applied DNA Sciences | 55 |
Aptose Biosciences | 36 |
Cellectar Biosciences | 20 |
Kiora Pharmaceuticals | 12 |
BioRestorative Therapies | 11 |
Can-Fite BioPharma | 8 |
Evoke Pharma | 4 |
EYEN News
- 15 days ago - Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewsWire
- 4 weeks ago - Eyenovia Provides Update on Restructuring Efforts - GlobeNewsWire
- 5 weeks ago - Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline - Benzinga
- 5 weeks ago - Eyenovia to discontinue late-stage study for eye drug - Reuters
- 5 weeks ago - Eyenovia Provides Update on Phase 3 CHAPERONE Study - GlobeNewsWire
- 5 weeks ago - Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th - GlobeNewsWire
- 2 months ago - Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo - GlobeNewsWire